Please login to the form below

Not currently logged in
Email:
Password:

product launch

This page shows the latest product launch news and features for those working in and with pharma, biotech and healthcare.

US approval for first ever cannabis-based medicine

US approval for first ever cannabis-based medicine

The company will have to wait a little longer before it can launch the product, however, because its active ingredient, CBD, needs to be rescheduled under US law. ... Once this recategorisation is completed within the next 90 days, GW Pharma will launch

Latest news

  • EMA approves GSK’s triple COPD therapy EMA approves GSK’s triple COPD therapy

    The EU regulator cleared Trelegy (fluticasone furoate/umeclidinium/vilanterol) - considered to be the most important new product in the company’s ailing respiratory franchise - as a maintenance treatment in adults with ... GSK said in a statement that

  • AZ gets early FDA green light for Imbruvica challenger AZ gets early FDA green light for Imbruvica challenger

    The new product - which will be sold in the US as Calquence - has been approved much earlier than expected, bringing forward a marketing battle with Johnson/AbbVie's big-selling Imbruvica ... The new product will launch with a list price of around $14,

  • GSK’s shingles vaccine Shingrix claims US approval GSK’s shingles vaccine Shingrix claims US approval

    Japan. The company says it intends to make the product available in the US shortly at a price of $280 per two-dose course, which is just a few dollars above ... GSK chief executive Emma Walmsley has said the treatments will see the company through a lean

  • Belgium's Ablynx enters the US market Belgium's Ablynx enters the US market

    Dan] brings many years of experience in setting up commercial organisations and leading multiple successful product launches in the USA. ... Commenting on his appointment, Mr Schneider added: "I am delighted to join Ablynx at this very important moment

  • Merck, Pfizer cue up first EU launches for PD-L1 drug Bavencio Merck, Pfizer cue up first EU launches for PD-L1 drug Bavencio

    The new product will be launched first in the UK and Germany, according to Merck, which developed the drug and whose Merck Serono unit will commercialise it in partnership with Pfizer ... For Merck the drug is part of a series of new products it hopes

More from news
Approximately 1 fully matching, plus 218 partially matching documents found.

Latest Intelligence

  • Effective sales performance Effective sales performance

    To take two extremes:. 1. New products are evaluated first by an individual trying a product. ... In short it is of no value to pursue laggard practices when you launch a new product, your targets should match the promotional focus at that stage of the

  • Positive disruption in business intelligence Positive disruption in business intelligence

    Three areas where insights-led tactics are emerging are in pre-launch awareness and advocacy; product differentiation; and market access. ... One pharmaceutical company, for example, studied the online conversations of nurses and pharmacists during its

  • Meetings Meetings

    For a product launch, it makes good sense to anticipate early on which person and agenda would provide the perfect fit and develop relationships to make this feasible.

  • Can big data give medical affairs an edge in strategic planning? Can big data give medical affairs an edge in strategic planning?

    For example, Medmeme’s product called Link enables medical affairs departments to link with the right scientific expert for the right endeavour and gather a wealth of information about them, such ... leading up to the launch of a new product.

  • Proving real-world value Proving real-world value

    Industry, payers and patients must, she says, partner to operationalise real-world evidence as intelligence to inform product innovation. ... If, when you launch a product, your ambition is to maximise sales, the development, research and commercial

More from intelligence
Approximately 0 fully matching, plus 27 partially matching documents found.

Latest appointments

  • Mereo BioPharma appoints head of patient access and commercial planning Mereo BioPharma appoints head of patient access and commercial planning

    Hughes-Wilson brings in-depth market access and product launch expertise as well as a proven ability to develop and lead commercial planning efforts globally. ... In this role, Hughes-Wilson was responsible for Sobi’s commercialisation approach and

  • Alacrita appoints Anna Casse as MD Alacrita appoints Anna Casse as MD

    Life science consulting firm Alacrita has appointed Anna Casse as its new managing director - a role that will see her assume responsibility for Alacrita Europe and help build its European Launch ... I am looking forward to driving further growth in the

  • Hanover Health bolsters PR leadership team Hanover Health bolsters PR leadership team

    Davies moves to Hanover Health from Tonic Life Communications where he was a senior account director specialising in oncology and neurology product communications, having first joined as an account director in ... 2011. She brings experience in pre- and

  • Dr Andrew Webber joins Life Healthcare Communications Dr Andrew Webber joins Life Healthcare Communications

    In his new in-house role, Dr Webber will be responsible for overseeing the global launch of a new product within the agency's service portfolio.

  • Former Boehringer diabetes marketing VP joins Gelesis Former Boehringer diabetes marketing VP joins Gelesis

    Dr Pass brings over 20 years of commercial expertise in the diabetes and metabolics areas among others to Gelesis, and takes on responsibility for all business development and product commercialisation, including ... Yishai Zohar, chief executive officer

More from appointments
Approximately 0 fully matching, plus 14 partially matching documents found.

Latest from PMHub

  • Biotech: it's a people business

    By developing a team of people who specialise and focus on the product, a company can nurture it along – often a small, novel or complex drug needs that in the beginning.

  • OUTiCO Case Study - Product Launch

    OUTiCO Case Study - Product Launch. POSITIVE FORMULARY SUCCESS WITHIN 8 MONTHS! ... CHALLENGE. New product launch. Limited market access capabilities in priority CCG/Health Boards.

  • An eye-catching product launch for lens manufacturer Rayner

    An eye-catching product launch for lens manufacturer Rayner. A case study by Create Health. ... PROJECT SCOPE. Fully integrated product launch campaign. Salesforce toolkit. Exhibition stand with performing artists.

  • Commercial innovation in biotech organisations

    Commercial innovation in biotech organisations. Blue Latitude Health speaks to Salma Jutt Vice President of US Marketing and Head of Commercial Innovation at a biotech specialising in treating weight loss and obesity. Image: Salma Jutt, Vice

  • Biosimilars: Getting the flock to market

    Our agency created the global launch campaign for the first biosimilar monoclonal antibody. ... So the key to an effective launch is to develop a distinctive Value Proposition, translated into a compelling creative platform.

More from PMHub
Approximately 5 fully matching, plus 7 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anatomy Health

We are a health information design consultancy focused on developing simple, accessible and inclusive patient communications. From evaluating existing patient...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics